Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Serum Institute to keep 200 mn vax doses ready by Jan
Pune's Serum Institute of India will have 200 million doses of the Astra Zeneca-Oxford University vaccine for the coronavirus ready by January, ramping up its capacity to make 100 million doses of the inoculation monthly.
New Delhi: Pune's Serum Institute of India will have 200 million doses of the Astra Zeneca-Oxford University vaccine for the coronavirus ready by January, ramping up its capacity to make 100 million doses of the inoculation monthly.
Sources said the company has recruited over 1,600 participants in India for phase 3 trials of Covishield (the AstraZeneca vaccine candidate).
All participants have received the first shot of the vaccine and by the end of November, the second shot would be completed. Data analysis would begin after the second shot, sources said. "SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses," said a source.About 50 per cent of its capacity will be for India, it said.
